Annual report pursuant to Section 13 and 15(d)

Segment Information - Summary of Reportable Segments (Detail)

v3.22.0.1
Segment Information - Summary of Reportable Segments (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]    
Revenues $ 203,018 $ 151,669
Gross profit 111,283 81,840
Depreciation and amortization 28,927 26,189
Asset impairments and write-downs 7,414 207,162
Net loss (76,248) (313,362)
Purchase of property, plant and equipment 19,440 13,435
Purchase of intangibles 959 821
Assets 346,744 353,133
Eastern Region    
Segment Reporting Information [Line Items]    
Revenues 128,979 91,149
Gross profit 84,863 57,549
Depreciation and amortization 16,885 14,346
Asset impairments and write-downs 221 23,299
Net loss 9,128 (58,424)
Purchase of property, plant and equipment 17,384 12,486
Purchase of intangibles 100 760
Assets 224,105 227,237
Western Region    
Segment Reporting Information [Line Items]    
Revenues 72,424 57,613
Gross profit 27,877 24,239
Depreciation and amortization 11,235 11,054
Asset impairments and write-downs   180,283
Net loss (2,792) (159,894)
Purchase of property, plant and equipment 2,024 780
Assets 106,485 109,039
Other    
Segment Reporting Information [Line Items]    
Revenues [1] 1,615 2,907
Gross profit (1,457) 52
Depreciation and amortization 807 789
Asset impairments and write-downs 7,193 3,580
Net loss (82,584) (95,044)
Purchase of property, plant and equipment 32 169
Purchase of intangibles 859 61
Assets $ 16,154 $ 16,857
[1] Revenues from segments below the quantitative thresholds are attributable to an operating segment of the Company that includes revenue from the sale of CBD products throughout the United States. This segment has never met any of the quantitative thresholds for determining reportable segments nor does it meet the qualitative criteria for aggregation with the Company’s reportable segments.